Galenica AG
GALE
Rang in aandelen
#3269
Galenica AG stands as a leading healthcare services company, serving both the... Galenica AG stands as a leading healthcare services company, serving both the Swiss market and international clients. Its operations are organized into two principal divisions: "Products & Care" and "Logistics & IT." The "Products & Care" division oversees an extensive network of 520 pharmacies, comprising 368 directly owned outlets and 152 partner-affiliated pharmacies, operating under the recognized brand names of Amavita, Sun Store, and Coop Vitality. Beyond retail pharmacy services, this segment also provides medication for patients receiving home-based treatment. It is also responsible for the introduction and distribution of a diverse portfolio of consumer health, pharmaceutical, and parapharmaceutical products, in addition to offering vital marketing and sales support to its collaborators within the healthcare sector. The "Logistics & IT" division specializes in offering a suite of pre-wholesale services tailored for pharmaceutical and healthcare enterprises. These services encompass essential functions such as secure storage, efficient distribution, and comprehensive debt collection. Furthermore, this segment provides various logistics and information technology solutions, including a master data system specifically developed for the healthcare industry. It actively creates advanced management solutions relevant to the healthcare market and publishes technical information on pharmaceutical products in both printed and electronic formats, alongside delivering complete management tools for pharmacies. Founded in 1927, Galenica AG maintains its headquarters in Bern, Switzerland.
Aandeelprijs
$107.82
Marktkapitalisatie
$5.37B
Verandering (1 dag)
0.62%
Verandering (1 jaar)
-4.43%
Land
CH
Handel Galenica AG (GALE)
Categorie
Healthcare
P/B-ratio voor Galenica AG (GALE)
P/B-ratio op October 2026 TTM: 3.14
Volgens de meest recente financiële rapporten en aandelenkoers van Galenica AG is de huidige P/B-ratio (TTM) 3.14. Eind 2024 had het bedrijf een P/B-ratio van 2.39.
P/B-ratiohistoriek voor Galenica AG van 2013 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 3.14 | -4.58% |
| 2025 | 3.29 | 37.34% |
| 2024 | 2.39 | -2.91% |
| 2023 | 2.46 | -18.30% |
| 2022 | 3.02 | 8.98% |
| 2021 | 2.77 | -0.59% |
| 2020 | 2.78 | -6.19% |
| 2019 | 2.97 | 30.65% |
| 2018 | 2.27 | -20.55% |
| 2017 | 2.86 | -56.16% |
| 2016 | 6.52 | -22.93% |
| 2015 | 8.46 | -9.34% |
| 2014 | 9.34 | 0.00% |
| 2013 | 0.00 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| -27.3394 | -970.90% |
US
|
|
| 21.5516 | 586.53% |
US
|
|
| -21.0755 | -771.37% |
US
|
|
| 11.394 | 262.96% |
US
|
|
| 6.4701 | 106.11% |
AU
|
